BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$267.55 USD
+3.58 (1.36%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $267.46 -0.09 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $2.12 | 4.02% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.04 per share. This reflects a positive earnings surprise of 12.25%. Look out for BIO's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $2.12 per share, reflecting a year-over-year decrease of 29.33%.
Earnings History
Price & Consensus
Zacks News for BIO
Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services